Hemorrhagic Occlusive Retinal Vasculitis From the Cataract Surgeon’s Perspective

In this interview from AAO 2016, Dr. David Chang discusses his perspective on hemorrhagic occlusive retinal vasculitis (HORV), a rare and devastating complication linked to use of intraocular vancomycin during cataract surgery. Dr. Chang participated in the HORV joint task force created by the American Society of Cataract and Refractive Surgeons (ASCRS) and the American Society of Retina Specialists (ASRS) to further define this condition. So far, 22 patients (36 eyes) have been identified. As a result of what he has learned, Dr. Chang has switched to moxifloxacin. Dr. Andre Witkin who published the initial series of 6 patients (11 eyes) in the July 2015 issue of Ophthalmology fully describes the clinical features in this video from ASRS 2016.